Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexsero for the Prevention of Gonococcal Infection
NCT04350138Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2020
- Primary completion
- Feb 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 2 trial of meningococcal group B vaccine in gonococcal infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 2020; status: completed.
02
Drugs
meningococcal group B vaccine
03
Conditions
gonococcal infection
Beyond the preview
Go deeper on NCT04350138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04350138.